Scientists from the Center for Genetic Engineering and Biotechnology (CIGB) together with researchers from the Cuban health system have been developing for a decade a promising vaccine candidate HeberSaVax to guarantee the survival of patients with liver cancer or hepatocarcinoma, a pathology that annually causes more than half a million deaths worldwide.
Read more HeberSaVax: Another achievement of Cuban biotechnologyThe territorial delegation of the Ministry of Science, Technology and Environment (Citma) in the province of Holguín calls for the Provincial Environment Award 2025, which is awarded to highlight the work of companies, organizations and individuals, in pursuit of the conservation of the environment.
Read more Holguín calls for 2025 Provincial Environment AwardPage 133 of 467